PAVmed Inc expected to post a loss of 25 cents a share - Earnings Preview

PAVmed

13/03/2023 13:37

* PAVmed Inc  PAVM.OQ   PAVM.O  is expected to show a fall
in
quarterly revenue when it reports  results on March 15. 
    * The New York City-based  company is expected to report  a
8.3% decrease in revenue to $275 thousand from $300 thousand a
year ago, according to the mean estimate from 4 analysts, based
on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for PAVmed Inc is for a
loss
of 25 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for PAVmed Inc
is
$2.25​, above​ its last closing price of $0.45. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Sep. 30 2022  -0.27       -0.26      -0.29     Missed  -9.4
 Jun. 30 2022  -0.23       -0.23      -0.29     Missed  -26.1
 Mar. 31 2022  -0.19       -0.19      -0.20     Missed  -2.6​
 Dec. 31 2021  -0.14       -0.15      -0.20     Missed  -33.3
 ​​Sep.        -0.14       -0.13      -0.15     Missed  -15.4
 30 2021                                                
 Jun. 30 2021  -0.10       -0.10      -0.14     Missed  -43.6​
 Mar. 31 2021  -0.12       -0.12      -0.13     Missed  -8.3
 Dec. 31 2020  -0.11       -0.11      -0.17     Missed  -50
 This summary was machine generated March 13 at 13:37 GMT.  All
figures in US dollars  unless otherwise stated